TM6SF2 and hepatocellular carcinoma: ,19,20 One retrospective study found a 29-fold higher risk of HCC associated with a GRS consisting of PNPLA3, TM6SF2, and HSD17B13,17 which is significantly higher than the ORs calculated in our study (3.6-fold).